M. Otto

Infectious Diseases · Nature Reviews Microbiology · 2001–2021

A researcher in the Science corpus: 13 papers; trusts 18 researchers and is trusted by 9 researchers here, as inferred from the citation graph.

Subfields

• Infectious Diseases — 107 citations into it; #83 of 589 by trust here, #63 by citations
• Molecular Biology — 97 citations into it; #5,469 of 17,773 by trust here, #3,963 by citations
• Public Health, Environmental and Occupational Health — 39 citations into it
• Epidemiology — 28 citations into it
• Clinical Biochemistry — 23 citations into it
• Microbiology — 23 citations into it
• Immunology — 18 citations into it
• Endocrinology — 13 citations into it

Whom M. Otto trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. R. Donlan
2. G. O’Toole
3. Henry F. Chambers
4. Blaise R. Boles
5. T. Mah
6. L. Marraffini
7. R. Novick
8. S. Mazmanian
9. V. Brinkmann
10. A. Horswill

Who trusts M. Otto overall

1. R. Vasudevan
2. T. Foster
3. Jing Yan
4. D. Limoli
5. Y. Belkaid
6. Ashley L. DuMont
7. J. Segre
8. Keith A. Jolley

Papers from M. Otto's perspective

Ordered by how strongly the researchers M. Otto trusts endorse each paper. Same corpus, a different order for every researcher.

1. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA (Nature Medicine)
2. Quorum Sensing in Staphylococcus aureus Biofilms (Journal of Bacteriology)
3. Allelic replacement in Staphylococcus aureus with inducible counter-selection. (Plasmid)
4. agr-Mediated Dispersal of Staphylococcus aureus Biofilms (PLoS Pathogens)
5. Bap, a Staphylococcus aureus Surface Protein Involved in Biofilm Formation (Journal of Bacteriology)
6. Rhamnolipid Surfactant Production Affects Biofilm Architecture in Pseudomonas aeruginosa PAO1 (Journal of Bacteriology)
7. Fruiting body formation by Bacillus subtilis (Proceedings of the National Academy of Sciences of the United States of America)
8. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. (Proceedings of the National Academy of Sciences of the United States of America)
9. Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms (Clinical Microbiology Reviews)
10. Isolation and Characterization of Human β-Defensin-3, a Novel Human Inducible Peptide Antibiotic* (Journal of Biological Chemistry)

Their papers

• Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system (2004) — 645 citations
• Staphylococcus aureus Resistance to Human Defensins and Evasion of Neutrophil Killing via the Novel Virulence Factor Mprf Is Based on Modification of Membrane Lipids with l-Lysine (2001) — 819 citations
• Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA (2007) — 1,064 citations
• Staphylococcus epidermidis – the “accidental” pathogen (2009) — 1,777 citations
• A Crucial Role for Exopolysaccharide Modification in Bacterial Biofilm Formation, Immune Evasion, and Virulence* (2004) — 607 citations
• Epidemic community-associated methicillin-resistant Staphylococcus aureus: Recent clonal expansion and diversification (2008) — 409 citations
• How Staphylococcus aureus biofilms develop their characteristic structure (2012) — 637 citations
• Pathogenicity and virulence of Staphylococcus aureus (2021) — 1,236 citations
• Staphylococcal biofilms (2018) — 881 citations
• Different drugs for bad bugs: Antivirulence strategies in the age of antibiotic resistance (2017) — 669 citations
• Identification and treatment of the Staphylococcus aureus reservoir in vivo (2016) — 159 citations
• Staphylococcus aureus toxins (2013) — 604 citations
• Community-associated methicillin-resistant Staphylococcus aureus (2010) — 1,217 citations